@article{ref1,
title="Treatments for the prevention and management of suicide",
journal="Annals of internal medicine",
year="2020",
author="D'Anci, Kristen E. and Uhl, Stacey",
volume="172",
number="2",
pages="168-168",
abstract="<p> IN RESPONSE: Clozapine is recognized and recommended as a treatment to reduce death by suicide among adults with schizophrenia or schizoaffective disorder in the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense (VA/DoD) clinical practice guideline on the assessment and management of patients at risk for suicide (1). This recommendation was carried forward from the previous VA/DoD guideline on the management of suicide published in 2013 and is based largely on the study by Meltzer and colleagues (2), which Dr. Kelly and associates cite. Because this study was included in the previous versions... </p> <p>Language: en</p>",
language="en",
issn="0003-4819",
doi="10.7326/L19-0707",
url="http://dx.doi.org/10.7326/L19-0707"
}